Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Self-assembled nano-sized probes

Abstract:
Penn researchers to see tumors through flesh and skin

Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin

Philadelphia, PA | February 7, 2005

Nano-sized particles embedded with bright, light-emitting molecules have enabled researchers to visualize a tumor more than one centimeter below the skin surface using only infrared light. A team of chemists, bioengineers and medical researchers based at the University of Pennsylvania and the University of Minnesota has lodged fluorescent materials called porphyrins within the surface of a polymersome, a cell-like vesicle, to image a tumor within a living rodent. Their findings, which represent a proof of principle for the use of emissive polymersomes to target and visualize tumors, appear in the Feb. 7 online early edition of the Proceedings of the National Academy of Science.

"We have shown that the dispersion of thousands of brightly emissive multi-porphyrin fluorophores within the polymersome membrane can be used to optically image tissue structures deep below the skin – with the potential to go even deeper," said Michael J. Therien, a professor of chemistry at Penn. "It should also be possible to use an emissive polymersome vesicle to transport therapeutics directly to a tumor, enabling us to actually see if chemotherapy is really going to its intended target."

This work takes advantage of years of effort in the Therien laboratory focused on the design of highly fluorescent compounds. Polymersomes, which were developed by Penn professors Daniel A. Hammer and Dennis Discher in the mid-1990s, function much like the bilayered membranes of living cells. Whereas cell membranes are created from a double layer of fatty phospholipid chains, a polymersome is comprised of two layers of synthetic co-polymers. Like a living cell, the polymersome membrane has a hydrophobic core. The study shows that the fluorophores evenly disperse within this core, giving rise to a nanometer-sized light-emitting structure.

"These polymers are also larger than phospholipids, so that there is enough space for the fluorophores, which are larger than the average molecule that is found inside cell membranes," said Hammer, professor and chair of the Department of Bioengineering at Penn's School of Engineering and Applied Sciences. " Another feature that makes emissive polymersomes so useful is that they self-assemble. Simply mixing together all component parts gives rise to these functional nanometer-sized, cell-like vesicles."

In their study, the researchers demonstrate how they can use these emissive polymersomes to target markers on the surface of a specific type of tumor cells. When exposed to near-infrared light, which can travel through tissue, the fluorophores within the polymersome respond with a bright near-infrared signal that can then be detected.

"The fluorophores function like reflectors stuck in the spokes of a bicycle tire," Therien said. "When this structure absorbs light, it gives rise to an intense, localized fluorescence signal that is uniquely suited for visualizing living biological systems."

According to Therein, there is keen interest in developing new technology that will enable optical imaging of cancer tissue, as such technology will be less costly and more accessible than MRI-based methods and free of the harmful side effects associated with radioactivity. In this imaging system, the flourophores can also be tuned to respond to different wavelengths of near-infrared light. This sets the stage for using emissive polymersomes to target multiple cancer cell-surface markers in the body simultaneously.

Emissive polymersomes perform much like in vivo imaging systems that use semiconductor-based "quantum dots." These quantum dots, however, are hard matter, which could collect within the circulatory system, potentially causing a stroke. According to the Penn researchers, brightly emissive polymersomes define the first nanotech optical imaging platform based on non-aggregating "soft matter" (polymers and porphyrins) and hence have enormous potential in biomedicine.

###


This research was supported by a National Cancer Institute research grant to Therien and a Biomedical Imaging and Bioengineering research grant to Hammer and Therien.

P. Peter Ghoroghchian, a graduate student in Penn's Department of Bioengineering, was the lead author on the study. Graduate student Paul R. Frail and senior research associate Kimihiro Susumu, both of Penn's Department of Chemistry, designed the emissive structures. Dana Blessington and Britton Chance of the Department of Biochemistry and Biophysics in Penn's School of Medicine performed the live-animal imaging experiments described in the paper. Co-authors Aaron K. Brannan and Frank S. Bates, from the Department of Chemical Engineering and Materials Science at the University of Minnesota, carried out cryogenic transmission electron microscope studies of the emissive polymersome structures and provided design principles for the polymers used in the study.



Contact:
Greg Lester
glester@pobox.upenn.edu
215-573-6604
University of Pennsylvania

Copyright © University of Pennsylvania

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

University of Minnesota

Related News Press

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project